CA2596802A1 - Lutte contre les allergenes mineurs en vue d'augmenter la securite d'une immunotherapie - Google Patents

Lutte contre les allergenes mineurs en vue d'augmenter la securite d'une immunotherapie Download PDF

Info

Publication number
CA2596802A1
CA2596802A1 CA002596802A CA2596802A CA2596802A1 CA 2596802 A1 CA2596802 A1 CA 2596802A1 CA 002596802 A CA002596802 A CA 002596802A CA 2596802 A CA2596802 A CA 2596802A CA 2596802 A1 CA2596802 A1 CA 2596802A1
Authority
CA
Canada
Prior art keywords
allergen
allergens
major
extract
minor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002596802A
Other languages
English (en)
Inventor
Domingo Barber Hernandez
Florentino Polo Corrales
Manuel Lombardero Vega
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ALK Abello AS
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2596802A1 publication Critical patent/CA2596802A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002596802A 2005-02-03 2006-02-03 Lutte contre les allergenes mineurs en vue d'augmenter la securite d'une immunotherapie Abandoned CA2596802A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US64909005P 2005-02-03 2005-02-03
DKPA200500177 2005-02-03
US60/649,090 2005-02-03
DKPA200500177 2005-02-03
PCT/DK2006/000057 WO2006081822A2 (fr) 2005-02-03 2006-02-03 Lutte contre les allergenes mineurs en vue d'augmenter la securite d'une immunotherapie

Publications (1)

Publication Number Publication Date
CA2596802A1 true CA2596802A1 (fr) 2006-08-10

Family

ID=36636654

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002596802A Abandoned CA2596802A1 (fr) 2005-02-03 2006-02-03 Lutte contre les allergenes mineurs en vue d'augmenter la securite d'une immunotherapie

Country Status (7)

Country Link
EP (1) EP1871413A2 (fr)
JP (1) JP2008528642A (fr)
KR (1) KR20070100914A (fr)
AU (1) AU2006209947A1 (fr)
CA (1) CA2596802A1 (fr)
MX (1) MX2007009216A (fr)
WO (1) WO2006081822A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR122021008456B1 (pt) * 2010-06-03 2021-08-03 Alk-Abelló A/S Métodos de fabricação de um extrato de alérgenos de ácaro de pó doméstico
EP2575832B1 (fr) * 2010-06-03 2017-07-26 ALK-Abelló A/S Produit pharmaceutique comportant des extraits d'allergène d'acarien et son procédé de fabrication

Also Published As

Publication number Publication date
JP2008528642A (ja) 2008-07-31
AU2006209947A1 (en) 2006-08-10
WO2006081822A3 (fr) 2006-11-02
EP1871413A2 (fr) 2008-01-02
WO2006081822A2 (fr) 2006-08-10
KR20070100914A (ko) 2007-10-12
MX2007009216A (es) 2008-01-16

Similar Documents

Publication Publication Date Title
US20110200641A1 (en) Minor allergen control to increase safety of immunotherapy
Heiss et al. Identification of a 60 kd cross-reactive allergen in pollen and plant-derived food
Valenta et al. Recombinant allergens: what does the future hold?
Cromwell et al. Recombinant allergens for specific immunotherapy
Gangl et al. Multiple grass mixes as opposed to single grasses for allergen immunotherapy in allergic rhinitis
Pellaton et al. Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptides
Larsen et al. Manufacturing and standardizing allergen extracts in Europe
Asturias et al. Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen‐specific immunotherapy
Linhart et al. Molecular evolution of hypoallergenic hybrid proteins for vaccination against grass pollen allergy
Linhart et al. A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6.
González-Rioja et al. Genetically engineered hybrid proteins from Parietaria judaica pollen for allergen-specific immunotherapy
US20150210742A1 (en) Novel allergen from ragweed pollen and uses thereof
Tabesh et al. Design and evaluation of a hypoallergenic peptide-based vaccine for Salsola kali allergy
US20090098167A1 (en) PHL P 1 Allergen Derivative
CA2596802A1 (fr) Lutte contre les allergenes mineurs en vue d'augmenter la securite d'une immunotherapie
RU2242248C2 (ru) Способ выделения и очистки аллергенов травяной пыльцы
González‐Rioja et al. Diagnosis of Parietaria judaica pollen allergy using natural and recombinant Par j 1 and Par j 2 allergens
AU2002242273B2 (en) Compositions of multimeric profilin for diagnosis and treatment of allergies
EP2875828B1 (fr) Composition pour l'administration intradermique d'allergoïdes
ES2436605T3 (es) Alérgenos recombinantes con reducción de la unión a IgE sin disminución de la antigenicidad para células T
Bonura et al. Isolation, expression and immunological characterization of a calcium-binding protein from Parietaria pollen
RU2761431C9 (ru) Рекомбинантный полипептид на основе аллергена пыльцы березы и аллергена яблока в качестве вакцины от аллергии
JP4881526B2 (ja) 牧草花粉Phlp6アレルゲンの非アナフィラキシー形態及びそれらの使用
Larsen et al. Manufacturing and standardizing allergen vaccines
WO2015054217A2 (fr) Méthodes et utilisations pour réduire une réaction allergique chez un sujet

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20130204